The year 2025 marks a decisive turning point in the evolution of military technology. Advances in genetics and biotechnology have paved the way for the creation of super-soldiers, modified to surpass traditional human capabilities. These beings, the result of sophisticated genetic manipulation, represent a new era of military power, but also a potential threat to global security.
As nations race to develop these fighters of a new kind, the ethical and strategic implications give rise to passionate debate. Is humanity ready to face the consequences of this technological revolution?
China’s strategic vision and military development
China is pursuing a bold ambition: to build a world-class military by 2049, centered on the concept of “intelligent warfare”. This strategy deeply integrates biotechnology and artificial intelligence, transforming the global security landscape. According to a report by the US Commission on Emerging Biotechnologies, the People’s Liberation Army (PLA) could develop genetically enhanced soldiers, combining biological augmentation and AI-assisted decision-making.
This is not science fiction, but a potential reality arising from China’s military-civilian fusion doctrine, which aims to blur the boundaries between civilian innovation and military capabilities.
Global implications and Chinese strategies
China’s military-civilian fusion doctrine has significant repercussions on the global biotechnology market. Relying on intellectual property theft, state-subsidized production and control of supply chains, China seeks to dominate this strategic sector. Entities such as the Beijing Genomics Institute (BGI) play a key role in this strategy, disrupting international markets with competitive pricing.
This approach is raising concerns about national security, prompting countries like India to adopt defensive measures. The prospect of genetically modified, AI-integrated PLA troops represents a strategic threat, potentially redefining the global military balance.
US strategic response to the Chinese threat
Faced with China’s rapid advance in the field of biotechnology, a report submitted to the US Congress recommends an urgent strategic response. It recommends accelerating domestic innovation by rigorously protecting intellectual property against Chinese state-sponsored theft, and limiting Chinese investment in sensitive sectors. A minimum federal investment of $15 billion over five years is suggested to stimulate domestic biotech innovation.
Artificial intelligence is identified as a crucial catalyst in this technological competition. Without decisive action, the United States risks being overtaken by genetically and numerically enhanced PLA soldiers, threatening the global military balance.
